Literature DB >> 34889419

Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy.

Ozlem Turan1,2, Rezan Abdul Kadir1,2.   

Abstract

Pregnancy and childbirth pose an important hemostatic challenge for women with von Willebrand disease (VWD) and can be associated with an increased risk of maternal and neonatal bleeding complications. VWD is a genetically and clinically heterogeneous bleeding disorder caused by a deficiency or an abnormality in the function of von Willebrand factor. Understanding inheritance pattern, hemostatic response to pregnancy, and response to treatment is essential for provision of individualized obstetric care and optimal outcome. A multidisciplinary approach to management with a close liaison between the obstetric team and the hemophilia treatment center is required for continuity of care from preconception counseling through to antenatal, peripartum, and postpartum care. Delivery plan must be coordinated by the multidisciplinary team and include decisions on place and mode of delivery, implementation of safe analgesia/anesthesia, and peripartum hemostasis. In this clinical case-based review, we aim to deliver evidence-based practical guidance for challenges encountered during pregnancy and management of childbirth and puerperium.
Copyright © 2021 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2021        PMID: 34889419      PMCID: PMC8791099          DOI: 10.1182/hematology.2021000321

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  48 in total

1.  Changes in the levels of factor VIII and von Willebrand factor in the puerperium.

Authors:  F Y Huq; A Kulkarni; E C Agbim; A Riddell; E Tuddenham; R A Kadir
Journal:  Haemophilia       Date:  2011-09-28       Impact factor: 4.287

2.  Pregnancy loss in women with von Willebrand disease: a single-center pilot study.

Authors:  Leslie Skeith; Natalia Rydz; Maeve O'Beirne; Dawn Goodyear; Haocheng Li; Man-Chiu Poon
Journal:  Blood Coagul Fibrinolysis       Date:  2017-07       Impact factor: 1.276

3.  Analgesia, anaesthesia and obstetric outcome in women with inherited bleeding disorders.

Authors:  Sean C Boyd; Anna D O'Connor; Maebh A Horan; Pat Dicker; Catherine Manning; C Lynch; C Regan; K Ryan; T Tan; B M Byrne
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2019-06-04       Impact factor: 2.435

4.  Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleeding.

Authors:  Yvonne V Sanders; Karin Fijnvandraat; Johan Boender; Evelien P Mauser-Bunschoten; Johanna G van der Bom; Joke de Meris; Frans J Smiers; Bernd Granzen; Paul Brons; Rienk Y J Tamminga; Marjon H Cnossen; Frank W G Leebeek
Journal:  Am J Hematol       Date:  2015-11-17       Impact factor: 10.047

5.  Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease.

Authors:  A H James; M G Jamison
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

6.  Puerperal loss (lochia) in women with or without inherited bleeding disorders.

Authors:  Claudia Chi; Mira Bapir; Christine A Lee; Rezan A Kadir
Journal:  Am J Obstet Gynecol       Date:  2010-04-24       Impact factor: 8.661

7.  Intracranial haemorrhage in von Willebrand disease: a report on six cases.

Authors:  V Labarque; A M Stain; V Blanchette; W H A Kahr; M D Carcao
Journal:  Haemophilia       Date:  2013-04-05       Impact factor: 4.287

Review 8.  Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.

Authors:  A Coppola; M Franchini; M Makris; E Santagostino; G Di Minno; P M Mannucci
Journal:  Haemophilia       Date:  2012-02-15       Impact factor: 4.287

9.  Intracranial haemorrhage in children with inherited bleeding disorders in the UK 2003-2015: A national cohort study.

Authors:  E A Chalmers; J Alamelu; P W Collins; M Mathias; J Payne; M Richards; O Tunstall; M Williams; B Palmer; A Mumford
Journal:  Haemophilia       Date:  2018-04-10       Impact factor: 4.287

Review 10.  The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.

Authors:  Mike A Laffan; Will Lester; James S O'Donnell; Andrew Will; Robert Campbell Tait; Anne Goodeve; Carolyn M Millar; David M Keeling
Journal:  Br J Haematol       Date:  2014-08-12       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.